MAMMOGRAPHY MARKET ANALYSIS

The global mammography market was valued at US$ 1,986.5 Mn in 2021 and is forecast to reach a value of US$ 3,640.7 Mn by 2028 at a CAGR of 9.0% between 2022 and 2028. The global mammography market is experiencing strong growth owing to the increase in burden/incidence of cancer across the world and favorable initiatives for breast cancer screening or increase in number of breast cancer screening programs/campaigns. Moreover, increasing number of mammography and biopsy procedures is expected to boost the growth of the market. However, factors such as risk of adverse effects from radiation exposure and growing emergence of other imaging or detection methods are expected to hamper growth of the market.

Global Mammography Market: Regional Insights

Based on geography, the global mammography market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Among regions, North America is expected to gain highest share in the market during the forecast period owing to the increasing prevalence of breast cancer and increasing demand for early-stage diagnosis in the region. For instance, mammogram is the specialized medical imaging tool used to look for early signs of breast cancer. According to the Centers for Disease Control and Prevention (CDC), breast cancer is the second most common cancer among women in the United States. Each year, about 264,000 cases of breast cancer are diagnosed in women and about 2,400 in men in the U.S. About 42,000 women and 500 men in the U.S. die each year from breast cancer.

Asia Pacific is also expected to witness robust growth in the global mammography market due to the increasing burden of breast cancer, rise in breast cancer screening campaigns, and favorable government initiatives in the region. For instance, According to the study by GLOBOCAN 2020, In India, every four minutes a woman is diagnosed with breast cancer. With around 178,000 new cases being diagnosed every year, the incidence of breast cancer has overtaken cervical cancer to become the most common cancer in Indian women. Thus, with the increase in burden of breast cancer, the use of mammogram is also increasing rapidly.

Figure 1. Global Mammography Market Share (%), by Region, 2021

To learn more about this report, request a free sample copy

Global Mammography Market Drivers:

Increase in burden/incidence of cancer across the world is expected to augment the growth of the global mammography market during the forecast period. For instance, mammograms are the best way to find breast cancer early, when it is easier to treat and before it is big enough to feel or cause symptoms. According to the World Cancer Research Fund International (WCRF), breast cancer is the most commonly occurring cancer in women and the most common cancer overall. There were more than 2.26 million new cases of breast cancer in women in 2020. According to WHO, in 2019, cancer is the first or second leading cause of death in 112 of 183 countries.

Favorable initiatives for breast cancer screening or increase in number of breast cancer screening programs or campaigns is expected to boost the growth of the global mammography market over the forecast period. For instance, in October 2020, the Kao Group of Japan announced the launch of the ‘Kao Group Pink Ribbon Campaign 2020’ in major cities across Japan. The campaign has been running since 2007 to communicate the importance of early detection of breast cancer to as many people as possible. Breast cancer is currently the most common type of cancer in Japanese females, driving the growth of the market.

Global Mammography Market Opportunities:

Increasing number of mammography and biopsy procedures is expected to offer significant growth opportunities for players in the global mammography market. For instance, according to the data provided by the U.S. Food & Drug Administration’s (USFDA) Mammography Quality Standards Act’s (MQSA) program, around 39,450,489 total annual mammography procedures were reported as of August 1, 2022 around the world. Mammography is a specialized medical imaging tool that uses a low-dose x-ray system to see inside the breasts. This in turn is expected to augment growth of the global mammography market.

Increase in awareness among people about breast cancer and mammography is expected to provide significant growth opportunities for players in the global mammography market. For instance, in October 2022, Kovai Medical Center and Hospital (KMCH) in association with Rotary Clubs of Coimbatore region launched ‘My Breast’, a mobile app to create awareness on breast cancer. ‘My Breast App’ has been designed to offer comprehensive information about breast cancer; symptoms, screening, self-examination, and treatment options, among others. This in turn is also expected to drive growth of the global mammography market.

Global Mammography Market Trends:

One of the major trends in the mammography market is the increasing use of digital mammography across the globe. Studies have shown that digital mammography detects up to 28% more cancers than film mammography in women 50 years of age and younger, pre- and perimenopausal women, and in women with dense breast tissue. A 28 percent increase in accuracy means earlier detection, and most importantly, a better chance of a cure. This trend is expected to continue over the forecast period, driving the growth of the global mammography market.

Moreover, with the growing advancements in the breast cancer treatment, increasing focus on the development of new products, and with mergers and acquisitions becoming more common, the global mammography market is expected to witness robust growth during the forecast period. This trend is expected to continue during the forecast period, driving the market growth.

Global Mammography Market Restraints:

Growing emergence of other imaging or detection methods, such as Magnetic Resonance Imaging (MRI), is expected to hinder growth of the global mammography market. For instance, growing emergence of other imaging/detection methods, such as MRI, is proving to be more cost-effective compared to mammography. MRI of the breast, or breast MRI, is a test used to detect breast cancer and other abnormalities in the breast. MRI is much more sensitive compared to mammography and can find invasive breast cancers sooner than mammograms,

Risk of adverse effects from radiation exposure is expected to hinder growth of the mammography market. For instance, mammographic procedures involve the patient to be exposed to multiple sets of radiations for therapeutic purposes. Radiation not only kills or slows the growth of cancer cells, it can also affect nearby healthy cells. Damage to healthy cells can cause side effects. The adverse effects from radiation exposure and risks associated with them are expected to restrain growth of the global mammography market over the forecast period.

Figure 2. Global Mammography Market Share (%), by Product Type, 2021

To learn more about this report, request a free sample copy

Global Mammography Market Segmentation:

The global mammography market report is segmented into Product Type, End-Users, and Geography.

Based on Product Type, the market is segmented into Digital Systems, Analog Systems, Breast Tomosynthesis, and Other Product Types. Out of which, Digital Systems Segment is expected to dominate the mammography market over the forecast period and this is attributed to the increase in use of digital mammography due to rise in demand for early-stage diagnosis among patients.

Analog Systems Segment is also expected to witness significant growth in the near future and this is owing to the rise in prevalence of breast cancer. In Analog mammography, low doses of radiation producing X-rays are used to detect the changes in tissues of the breasts.

Based on End-Users, the market is segmented into Hospitals, Specialty Clinics, and Diagnostic Centers. Out of which, Hospitals Segment is expected to dominate the market over the forecast period and this is attributed to the increase in burden of breast cancer, as most of the screening procedures are done in the hospitals.

Specialty Clinics Segment is also expected to witness significant growth in the near future and this is owing to the increase in number of diagnostic/screening, minimally invasive procedures as well as noninvasive procedures.

Global Mammography Market: Key Developments

In October 2020, GE Healthcare introduced Serena Bright in the U.S., which is claimed to be the industry's first contrast-enhanced guided biopsy solution.

In October 2020, Siemens Healthineers received clearance from the United States Food and Drug Administration (FDA) for Ysio Max digital radiography system which includes new detectors and usability features that improve imaging and speed up exams.

In July 2019, FUJIFILM’s American subsidiary launched its Tomosynthesis Biopsy option for the ASPIRE Cristalle mammography system. With the new option, clinicians can enhance diagnostic care for patients by using Tomosynthesis Biopsy to target lesion previously undetectable on images from full-field digital mammography (FFDM) alone.

Global Mammography Market: Key Companies Insights

The global mammography market is highly competitive. This is attributed to the rise in burden of breast cancer across the globe, as a result, players in the market are focusing on launching novel products in the market to meet increase in demand.

Some of the key players in the global mammography market are

Canon Medical Systems, Carestream Health, Siemens Healthineers, Planmed Oy, Konica Minolta Inc., Metaltronica SpA, Koninklijke Philips NV, General Medical Merate SpA, Hologic Inc., GE Healthcare, and Fujifilm Holdings Corporation, among others.

*Definition: A mammography exam, a mammogram, aids in the early detection and diagnosis of breast diseases in women. Mammography is specialized medical imaging tool that uses a low-dose x-ray system to see inside the breasts. Regular mammograms are the best tests doctors have to find breast cancer early.